EN Bouygues SA

Bouygues: Monthly disclosure of the total number of shares and voting rights

Bouygues: Monthly disclosure of the total number of shares and voting rights

REGULATED INFORMATION

MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS

Paris, 01/04/2025

Article 223-16 of the AMF General Regulation

 



Date



  		 



Shares



  		 



Voting rights
 



Theoretical (1) 		 



Exercisable (2)
   31 March 2025 379,124,771 486,589,607 484,175,145

(1)  In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all the shares to which voting rights are attached, including shares for which voting rights have been suspended.





(2)  For information purposes only, this number has been calculated net of the shares for which voting rights have been suspended.



The information is also available in the "" section of the Bouygues website.

BOUYGUES SA

A French Société Anonyme with share capital of €378,957,797

Registered office: 32, avenue Hoche, 75008 Paris, France

Reg No. 572 015 246 Paris - I.E. FR 29 572 015 246

Attachment



EN
01/04/2025

Underlying

ENBouygues SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bouygues SA

Carole Braudeau
  • Carole Braudeau
ORA ORANGE SA
EN BOUYGUES SA ... (+5)

Credit Morning 09/10/2025

Kering: First speech from Luca De Meo and Puma’s stake under review at Artemis|

ORA ORANGE SA
EN BOUYGUES SA
DBG DERICHEBOURG SA
KER KERING SA
CIRSA CIRSA ENTERPRISES S.A.
3h / 43m 3h / 43m 1 EN
Carole Braudeau
  • Carole Braudeau
ORA ORANGE SA
EN BOUYGUES SA ... (+5)

Morning Crédit 10/09/2025

Kering : premiers mots de Luca De Meo et confirmation de l’étude d’options pour Puma chez Artemis|

ORA ORANGE SA
EN BOUYGUES SA
DBG DERICHEBOURG SA
KER KERING SA
CIRSA CIRSA ENTERPRISES S.A.
4h / 1m 4h / 1m 1 FR
Stephane Beyazian ... (+2)
  • Stephane Beyazian
  • Sven Edelfelt
09/05/25 September 5, 2025 1 EN
Stephane Beyazian ... (+2)
  • Stephane Beyazian
  • Sven Edelfelt
09/05/25 September 5, 2025 1 FR
Martin Marandon-Carlhian ... (+4)
  • Martin Marandon-Carlhian
  • Oliver Metzger
  • Sinan Doganli
  • Stephane Houri
IFX INFINEON TECHNOLOGIES AG
FME FRESENIUS MEDICAL CARE AG
VIE VEOLIA ENVIRONNEMENT SA
ENGI ENGIE SA.
KPN ROYAL KPN NV
ROG ROCHE HOLDING LTD
CBK COMMERZBANK AG
NOVN NOVARTIS AG
EVT EVOTEC SE
EN BOUYGUES SA
HNR1 HANNOVER RUECK SE
AFX CARL ZEISS MEDITEC AG
SRT3 SARTORIUS AG PREF
GLJ GRENKE AG
UTDI UNITED INTERNET AG
ELG ELMOS SEMICONDUCTOR SE
SDF K+S AG
ZAL ZALANDO SE
BAS BASF SE
SAN SANOFI
FRE FRESENIUS SE & CO. KGAA
BAYN BAYER AG
DTE DEUTSCHE TELEKOM AG
TLX TALANX AG
IMPN IMPLENIA AG
AIXA AIXTRON SE
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
BC8 BECHTLE AG
ADN1 ADESSO AG
SAX STROEER SE & CO. KGAA
EVK EVONIK INDUSTRIES AG
WAF SILTRONIC AG
SMHN SUESS MICROTEC AG
FNTN FREENET AG
AZN ASTRAZENECA PLC
BIM BIOMERIEUX SA
DUE DURR AG
BFSA BEFESA SA
SANT S&T AG
AEIN ALLGEIER HOLDING AG
HAG HENSOLDT AG
NA9 NAGARRO
FPE3 FUCHS PETROLUB SE
SPAC 468 SPAC I SE
GSK GSK PLC
IOS IONOS GROUP SE
NOVO B NOVO NORDISK A/S
SCHOTT PHARMA AG
CVC CVC CAPITAL PARTNERS PLC
09/04/25 September 4, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch